It's important to consider your comfort with risk before diving in.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry ...

If you’re looking to diversify outside of AI, especially as AI investors look to trim their winners to save up for that mega-cap AI IPO boom on the horizon, with SpaceX leading the way, the biotech ...

Biogen Inc. (BIIB) is a leading biotechnology company focused on discovering, developing, and delivering therapies for ...

Biotech stocks are attracting investors as M&A activity, valuations and upcoming catalysts help drive sector momentum.

Small biotech stocks offer high rewards alongside a healthy dose of risk. Ultimately, 2026 is shaping up to be a year of validation for these diverse therapeutic approaches. Between Axsome's pivot ...

On May 20, JonesResearch updated its coverage on Relay Therapeutics Inc. (NASDAQ:RLAY) after reviewing encouraging initial ...

DENVER, May 22, 2026 (GLOBE NEWSWIRE) -- (www.247marketnews.com) – The biotechnology sector continues attracting speculative capital as investors aggressively position around next-generation oncology, ...

Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.